- Home
- PPC vs ASND Comparison
PPC vs ASND Comparison
Compare PPC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPC | ASND |
|---|---|---|
| Founded | 1946 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 12.8B |
| IPO Year | 1987 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PPC | ASND |
|---|---|---|
| Price | $37.15 | $212.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 15 |
| Target Price | $46.33 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 957.4K | 700.6K |
| Earning Date | 02-11-2026 | 02-11-2026 |
| Dividend Yield | ★ 22.37% | N/A |
| EPS Growth | ★ 24.34 | N/A |
| EPS | ★ 5.16 | N/A |
| Revenue | ★ $18,351,780,000.00 | $758,592,045.00 |
| Revenue This Year | $3.95 | $98.90 |
| Revenue Next Year | $0.51 | $83.74 |
| P/E Ratio | $7.28 | ★ N/A |
| Revenue Growth | 1.76 | ★ 97.46 |
| 52 Week Low | $35.73 | $118.03 |
| 52 Week High | $57.16 | $229.94 |
Technical Indicators
Market Signals| Indicator | PPC | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 35.34 | 53.38 |
| Support Level | $38.72 | $204.50 |
| Resistance Level | $40.02 | $215.98 |
| Average True Range (ATR) | 0.72 | 7.45 |
| MACD | -0.27 | 0.25 |
| Stochastic Oscillator | 2.47 | 67.58 |
Price Performance
Historical ComparisonAbout PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed that JBS' offer undervalued Pilgrim's Pride.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.